` BTMD (biote Corp) vs S&P 500 Comparison - Alpha Spread

b
BTMD
vs
S&P 500

Over the past 12 months, BTMD has underperformed S&P 500, delivering a return of -48% compared to the S&P 500's +18% growth.

Stocks Performance
BTMD vs S&P 500

Loading
BTMD
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
BTMD vs S&P 500

Loading
BTMD
S&P 500
Difference
www.alphaspread.com

Performance By Year
BTMD vs S&P 500

Loading
BTMD
S&P 500
Add Stock

Competitors Performance
biote Corp vs Peers

S&P 500
BTMD
LLY
JNJ
NOVO B
ROG
Add Stock

biote Corp
Glance View

Market Cap
208.5m USD
Industry
Pharmaceuticals

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas. The company went IPO on 2021-03-02. The firm provides components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. Its Biote Method is a comprehensive, end-to-end practice-building platform that provides Biote-certified practitioners with components specifically developed for practitioners in the hormone optimization space, such as Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The firm trains practitioners how to identify and treat early indicators of hormone-related aging conditions. The company also sells a complementary Biote-branded line of dietary supplements.

BTMD Intrinsic Value
9.77 USD
Undervaluation 58%
Intrinsic Value
Price
b
Back to Top